Solid Biosciences Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $39.1M | $171.2M | $154.7M |
| FY2021 | $24.2M | $232.4M | $119.1M |
| FY2022 | $48.6M | $260.3M | $155.4M |
| FY2023 | $38.5M | $164.9M | $74.0M |
| FY2024 | $51.4M | $188.7M | $80.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $39.1M | $171.2M | $154.7M |
| FY2021 | $24.2M | $232.4M | $119.1M |
| FY2022 | $48.6M | $260.3M | $155.4M |
| FY2023 | $38.5M | $164.9M | $74.0M |
| FY2024 | $51.4M | $188.7M | $80.2M |